The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective

Journal of Biochemistry and Molecular Biology

Volumn 38, Issue 3, 2005, Pages 300-306

  El Beshbishy, Hesham A ^a,b  

^a Al Azhar University   (Egypt)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Dimethyl dimethoxy biphenyl dicarboxylate; Glutathione peroxidase; Glutathione S transferase; Reduced glutathione; Tamoxifen; Thiobarbituric acid reactive substance

Indexed keywords

BIPHENYL DERIVATIVE; DICARBOXYLIC ACID; TAMOXIFEN;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; LIVER; OXIDATIVE STRESS; PATHOLOGY; RAT;

ANIMALS; BIPHENYL COMPOUNDS; DICARBOXYLIC ACIDS; FEMALE; LIVER; OXIDATIVE STRESS; RATS; TAMOXIFEN;

EID: 25444471536     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2005.38.3.300     Document Type: Article

References (54)

1. Akcay, T., Dinner, Y., Kayali, R., Colgar, U., Oral, E. and Cakatay, U. (2000) Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal womwn. J. Toxicol. Environ. Health 59, 1-5.
2. Ali, S. and Coombes, R. C. (2002) Endocrine responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2, 101-112.
3. Atalay, G., Dirix, L., Biganzoli, L., Beex, L., Nooij, M., Cameron, D. and Lohrisch, C. (2004) The effect of exemestane on serum lipids profile in postmenopausal women with metastatic breast cancer. Ann. Oncol. 15, 211-217.
4. Athoupa, M., Hirsimaki, P., Parssinen, R. and Mantyla, E. (1994) Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in rats. Carcinogenesis 15, 863-868.
5. Baek, M. S., Kim, J. Y., Myung, S. W., Yim, Y. H., Jeong, J. H. and Kim, D. H. (2001) Metabolism of DDB by human liver microsomal cytochrome P450: probable involvement of CYP3A and CYP1A2. Drug Metab. Dispos. 29, 381-388.
6. Bensky, D. and Gamble A. (1993) Traditional indications of DDB; in Chinese Herbal Medicine, Medica, M. (eds), pp. 110-112, Eastland Press, Seattle, USA.
7. Caballero, F., Gerez, E., Oliveri, L., Falcolff, N., Battle, A. and Vazquez, E. (2001) On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminobenzene in CF1 mice. Int. J. Biochem. Cell. Biol. 33, 681-690.
8. Clairborne, A. (1985) Catalase activity; in Handbook of Methods for Oxygen Radical Research, Greenwald, R. A. (ed.), p. 383, CRC press, Boca Raton, USA.
9. Dehal, S. S. and Kupfer, D. (1997) CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver, Cancer Res. 57, 3402-3406.
10. Dehal, S. S. and Kupfer, D. (1999) Cytochrome P450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins. Drug Metab. Dispos. 27, 681-688.
11. Desai, P., Nallani, S., Sane, R., Moore, L., Goodwin, B., Buckley, D. and Buckley, A. (2002) Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen. Drug Metab. Dispos. 30, 608-612.
12. Diplock, A. T., Rice, C. A. and Burdon, R. H. (1994) Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention. Cancer. Res. 54, 1952-1956.
13. Dragon, Y. P., Xu, Y. D. and Pilot, H. C. (1998) Tumour promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Prev. Med. 20, 15-26.
14. Ellman, G. L. (1959) Tissue sulfahydryl groups. Arch. Biochem. Biophys. 82, 70-77.
15. Emile, F. N., Dragan, Y. P., Colin, R. J., Jordan, V. C. and Pitot, H. C. (1995) Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Cancer Res. 55, 1780-1786.
16. Fu, T. and Liu, G. (1992) Protective effects of dimethyl-4,4′ dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′- dicarboxylate on damages of isolated rat hepatocytes induced by carbon tetrachloride and D-galactosamine. Biomed. Environ. Sci. 5, 185-194.
17. Habig, W. H., Pabst, M. J. and Jakoby, W. B. (1974) Glutathione-S- transferases. The first enzymatic step in mercaptouric acid formation. J. Biol. Chem. 249, 7130-7139.
18. Han, Y. and Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52, 1360-1363.
19. Hard, G. C., Iatropoulos, M. J., Jordan, K., Kaltenberg, O. P., Imondi, A. R. and Williams, G. M. (1993) Major difference in the hepatocarcinogenecity and DNA adduct forming ability between toremifene and tamoxifen in female rats. Cancer Res. 53, 4534-4541.
20. Hellmann-Blumberg, U., Taras, T. L., Wurz, G. T. and DeGreorio, M. W. (2000) Genotoxic effects of the novel antiestrogenic FC-1271a in comparison to tamoxifen and toremifene. Breast Cancer Res. Treat. 60, 63-70.
21. Hemminki, K., Widlak, P. and Hou, S. M. (1995) DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis 16, 1661-1664.
22. Hong, Y. H. (1986) Antibacterial effect of DDB; in Oriental Materia Medica: A Concise Guide, p. 65, Oriental Healing Arts Institute, Long Beach, USA.
23. Ip, S. P., Yiu, H. Y. and Ko, K. M. (2000) Differential effects of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice. Mol. Cell Biochem. 205, 111-114.
24. Jordan, V. C. (2003) Tamoxifen: a most unlikely pioneering medicine. Natl. Rev. Drug. Discov. 2, 205-213.
25. Karki, A., Mantyla, E., Hirsimaki, Y., Karlsson, S., Toikkanen, S. and Hirsimaki, P. (2000) Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Arch. Toxicol. 74, 249-256.
26. Kim, J., Back, M., Lee, S., Kim, S., Dong, M., Kim, B. and Kim, D. (2001) Characterization of the Selectivity and Mechanism of Cytochrome P450 Inhibition by Dimethyl-4,4′-dimethoxy-5,6,5′,6′- dimethylenedioxybiphenyl-2,2′-dicarboxylate, Drug Metab. Dispos. 29, 1555-1560.
27. Kim, S. N., Kim, S. Y., Yim, S. Y., Lee, W. Y., Ham, K. S., Kim, S. K., Yoon, M. Y. and Kim, Y. C. (1999) Effect of dimethyl-4,4′-dimethoxy-5,6, 5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) on chemical induced liver injury. Biol. Pharm. Bull. 22, 93-95.
28. Kupfer, D., Mani, C., Lee, C. and Rifkind, A. (1994) Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF. Cancer Res. 54, 3140-3144.
29. Letteron, P., Labbe, G., Degott, C., Berson, A., Fromenty, B., Delaforge, M., Larrey, D. and Pessayre, D. (1990) Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem. Pharmacol. 39, 2027-2034.
30. Li, X. J., Zhao, B. L., Liu, G. T. and Xin, W. J. (1990) Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic. Biol. Med. 9, 99-104.
31. Li, X. Y. (1991) Bioactivity of neolignans from fructus Schizandrae. Mem. Inst. Oswaldo Cruz. 86, 31-37.
32. Liu, G. T. (1989) Pharmacological actions and clinical use of fructus Schizandrae. Chin. Med. J. 102, 740-749.
33. Liu, C. S., Fang, S. D., Huang, M. F., Kao, Y. L. and Hsu, J. S. (1978) Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds. Sci. Sin. 21, 483-502.
34. Liu, Z., Shi, H. Y., Nawaz, Z. and Zhang, M. (2004) Tamoxifen induces the expression of maspin through estrogen receptor alpha. Cancer Lett. 209, 55-65.
35. Lu, H. and Liu, G. T. (1991) Effect of dibenzo[a,c]cyclootene lignans isolated from fructus Schizandrae on lipid peroxidation and anti-oxidative enzyme activity. Chem. Biol. Interact. 78, 77-84.
36. McCay, P. B., Lai, E. K., Poyer, J. L., Dubose, C. M. and Janzen, E. C. (1984) Oxygen and carbon centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J. Biol. Chem. 259, 2135-2143.
37. Oge, A., Sezer, E. D., Ozgonul, M., Bayraktar, F. and Sozmen, E. Y. (2003) The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovarictomized rats. Neurosci. 338, 217-220.
38. Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Anal. Biochem. 95, 351-358.
39. Pagano, G., deBiase, A., Deeva, I. B., Degan, P., Doronin, Y. K., Iaccarino, M., Oral, R. and Korkina, L. G. (2001) The role of oxidative stress in development and reproductive toxicity of tamoxifen. Life Sci. 68, 1735-1749.
40. Palomero, J., Galan, A. I., Munoz, M. E., Tunon, M. J., Gonzalez-Gallego, J. and Jimenez, R. (2001) Effects of aging on the susceptibility to the toxic effects of cyclosporine A in rats. Changes in liver glutathione and antioxidant enzymes. Free Rad. Biol. Med. 30, 836-845.
41. Panossian, A. G., Oganessian, A. S., Ambartsumian, M., Gabrielian, E. S., Wagner, H. and Wikman, G. (1999) Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine 9, 17-26.
42. Qi-Change, X., Lin, L., Degao, W. and Gen-Jun, X. (1987) Microassay of glutathione peroxidase by reduced phase HPLC. Chromatogram 9, 11-14.
43. Rosen, G. M., Britigan, B. E., Halpern, H. J. and Pou, S. (1999) Spin trapping free radicals in biological systems; in Free Radicals, Biology and Detection by Spin Trapping, p. 394, New York: Oxford Press, Oxford, United Kingdom.
44. Saarto, T., Blomqvist, C., Ehnholm, C., Taskinen, M. R. and Elomaa, I. (1996) Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen on plasma lipid levels in postmenopausal women. J. Clin. Oncol. 14, 429-433.
45. Simeone, A. M., Ekmikciolu, S., Grimm, E. A. and Tari, A. M. (2002) A novel mechanism by which retinamide inhibits breast cancer growth: the production of nitric oxide. Mol. Cancer Ther. 1, 1366.
46. Sinclair, S., (1998) Chinese herbs: a clinical review of astragalus, ligusticum, and schizandrae. Altern. Med. Rev. 3, 338-344.
47. Sridar, C., Kent, M., Notley, L., Gillam, E. and Hollenberg, P. (2002) Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6. Pharmacol. Exp. Therapeutics 301, 945-952.
48. Stanley, L. A., Carthew, P., Davies, R., Higginson, F., Martin, E. and Stayles, J. A. (2001) Delayed effects of tamoxifen in hepatocarcinogenesis. Cancer Lett. 171, 27.
49. Stefano, G. B., Cadet, P., Mantione, K., Cho, J. J., Jones, D. and Zhu, W. (2003) Estrogen signaling at the cell surface coupled to nitric oxide release in Mytilus edulis nervous system. Endocrinology 144, 1234-1240.
50. Williams, G. M., Iatropoulos, M. J., Djordjevic, M. V. and Kaltenberg, O. P. (1993). The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 14, 315-317.
51. White, B. A., Erickson, M. M. and Stevens, S. C. (1970) Determination of sGoT and sGPT enzymes; in Chemistry for Medical Technologists, pp. 293-296, Mosby, Saint Louis, USA.
52. Yu, F. L. and Bender, W. (2002) A proposed mechanism of tamoxifen in breast cancer prevention. Cancer Detect. Prev. 26, 370-375.
53. Yu, H. Q., Yang, X. U., Zang, Y. X. and Shi, J. Z. (1987) Biphenyl-dimethyl dicarboxylate in treating and preventing hepatitis due to drug poisoning. Chinese Med. J. Peking. 100, 122-123.
54. Zohny, S., Kandil, E., Moselhy, S. and Mohamed, E. (2001) Antioxidant properties of biphenyl dimethyl dicarboxylate, silymarin and garlic homogenates in carbon tetrachloride-induced rat liver injury. Egy. J. Biochem. Mol. Biol. 20, 47-62.